CHINOOK THERAPEUTICS, INC.
CHINOOK THERAPEUTICS, INC. (KDNY) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 182 transactions totaling $104.7M, demonstrating a bearish sentiment with -$48.6M in net insider flow. The most recent transaction on Aug 11, 2023 involved a transaction of 3,300 shares valued at $0.
KDNY Insider Activity Summary
Who Is Buying KDNY Stock?
No significant insider buying has been recorded for KDNY in the recent period.
Who Is Selling KDNY Stock?
No significant insider selling has been recorded for KDNY in the recent period.
Is CHINOOK THERAPEUTICS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KDNY is bearish with an Insider Alignment Score of 27/100 and a net flow of -$48.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
KDNY Frequently Asked Questions
Understanding KDNY Insider Activity
Insider trading at CHINOOK THERAPEUTICS, INC. (KDNY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading KDNY stock, having executed 182 transactions in the past 90 days. The most active insider is Davis Jerel (Executive), who has made 49 transactions totaling $43.1M.
Related Tools
Track CHINOOK THERAPEUTICS, INC. Insider Activity
Get notified when executives and directors at KDNY file new Form 4 transactions